{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:55:39Z","timestamp":1791939339390,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2022R1C1C1009626"],"award-info":[{"award-number":["NRF-2022R1C1C1009626"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003706","name":"Korea Research Institute of Standards and Science","doi-asserted-by":"publisher","award":["KRISS-2023-GP2023-0006"],"award-info":[{"award-number":["KRISS-2023-GP2023-0006"]}],"id":[{"id":"10.13039\/501100003706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.heliyon.2023.e21742","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T02:30:00Z","timestamp":1698460200000},"page":"e21742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses"],"prefix":"10.1016","volume":"9","author":[{"given":"Zijun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namki","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-2137","authenticated-orcid":false,"given":"Hee Min","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e21742_bib1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.heliyon.2023.e21742_bib2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2023.e21742_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit vaccines against emerging pathogenic human coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009576","article-title":"DC\/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist","volume":"17","author":"Th\u00e9paut","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2023.e21742_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009064","article-title":"Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: protection of mice after a single immunization","volume":"17","author":"Hennrich","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2023.e21742_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58603","article-title":"SARS-CoV-2 strategically mimics proteolytic activation of human ENaC","volume":"9","author":"Anand","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.heliyon.2023.e21742_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e21742_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41422-020-00430-4","article-title":"The SARS-CoV-2 spike protein: balancing stability and infectivity","volume":"30","author":"Berger","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2023.e21742_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.pathol.2020.09.006","article-title":"Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent","volume":"52","author":"Kaufer","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.heliyon.2023.e21742_bib10","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.7150\/ijbs.59184","article-title":"Construction and applications of SARS-CoV-2 pseudoviruses: a mini review","volume":"17","author":"Chen","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2023.e21742_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cbin.11517","article-title":"Dysregulation of the immune response in coronavirus disease 2019","volume":"45","author":"Mohamed Khosroshahi","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.heliyon.2023.e21742_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40001-020-00454-x","article-title":"A meta-analysis of the impact of COVID-19 on liver dysfunction","volume":"25","author":"Wu","year":"2020","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.heliyon.2023.e21742_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12974-017-0902-x","article-title":"Interleukin-1 receptor type 1 is overexpressed in neurons but not in glial cells within the rat superficial spinal dorsal horn in complete Freund adjuvant-induced inflammatory pain","volume":"14","author":"Hollo","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2023.e21742_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1189\/jlb.3A0614-313RRR","article-title":"Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells","volume":"99","author":"V Fernandez","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2005-02-0456","article-title":"IL-6 blocks a discrete early step in lymphopoiesis","volume":"106","author":"Maeda","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2023.e21742_bib16","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.15710","article-title":"Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.heliyon.2023.e21742_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-022-00852-9","article-title":"A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies","volume":"29","author":"Kumari","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.heliyon.2023.e21742_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115503","article-title":"Bench-to-bedside: innovation of small molecule anti-SARS-CoV-2 drugs in China","volume":"257","author":"Yang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e21742_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103579","article-title":"COVID-19 therapeutics: small-molecule drug development targeting SARS-CoV-2 main protease","volume":"28","author":"Kronenberger","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2023.e21742_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/20477724.2021.1890887","article-title":"Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection","volume":"115","author":"Galan","year":"2021","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.heliyon.2023.e21742_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06348-5","article-title":"Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial","volume":"21","author":"Vallejos","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e21742_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2225-4110.124335","article-title":"Antiviral natural products and herbal medicines","volume":"4","author":"Lin","year":"2014","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.heliyon.2023.e21742_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s13346-019-00691-6","article-title":"Antiviral effect of phytochemicals from medicinal plants: applications and drug delivery strategies","volume":"10","author":"Ben-Shabat","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.heliyon.2023.e21742_bib24","article-title":"A critical review on immunomodulatory peptides from plant sources; action mechanisms and recent advances","author":"Ashaolu","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.heliyon.2023.e21742_bib25","article-title":"Immunomodulatory functional foods and their molecular mechanisms","volume":"54","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2023.e21742_bib26","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1021\/acsomega.2c06451","article-title":"Attenuation of lipopolysaccharide-induced inflammatory responses through inhibition of the NF-\u03baB pathway and the increased NRF2 level by a flavonol-enriched n-butanol fraction from uvaria alba","volume":"8","author":"Notarte","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.heliyon.2023.e21742_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ptr.2321","article-title":"A new antifungal and antiprotozoal depside from the Andean lichen Protousnea poeppigii","volume":"22","author":"Schmeda-Hirschmann","year":"2008","journal-title":"Phyther. Res."},{"key":"10.1016\/j.heliyon.2023.e21742_bib28","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3109\/13880209.2014.889175","article-title":"Clair, in vitro evaluation of the antibacterial activity of extracts from 34 species of North American lichens","volume":"52","author":"Shrestha","year":"2014","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/metabo13070805","article-title":"Bioactive lichen secondary metabolites and their presence in species from Chile","volume":"13","author":"Poulsen-Silva","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.heliyon.2023.e21742_bib30","first-page":"578","article-title":"Melanogenesis inhibitory effects of methanolic extracts of Umbilicaria esculenta and Usnea longissima","volume":"45","author":"Kim","year":"2007","journal-title":"J. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146342","article-title":"Evaluation of anticancer and antioxidant activity of a commercially available CO2 supercritical extract of old man's beard (Usnea barbata)","volume":"11","author":"Zugic","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e21742_bib32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3906\/biy-1405-23","article-title":"Genotoxic, cytotoxic, and apoptotic effects of crude extract of Usnea filipendula Stirt. in vitro","volume":"38","author":"\u00c7eli\u0307kler Kasimo\u011fullari Seyhan Oran Ferda Ari","year":"2014","journal-title":"Turkish J. Biol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib33","article-title":"Bioactive natural products in COVID-19 therapy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113869","article-title":"Chinese herbal medicine: fighting SARS-CoV-2 infection on all fronts","volume":"270","author":"Wang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/md17070422","article-title":"Mycousfurans A and B, antibacterial usnic acid congeners from the fungus mycosphaerella sp., isolated from a marine sediment","volume":"17","author":"Lee","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.heliyon.2023.e21742_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/plants10050909","article-title":"Antioxidant and cytotoxic activities of Usnea barbata (L.) F.H. Wigg. Dry extracts in different solvents","volume":"10","author":"Popovici","year":"2021","journal-title":"Plants"},{"key":"10.1016\/j.heliyon.2023.e21742_bib37","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.3390\/ijms131114707","article-title":"Biological activities of Toninia candida and Usnea barbata together with their norstictic acid and usnic acid constituents","volume":"13","author":"Rankovic","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e21742_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010054","article-title":"Secondary metabolite profiling of species of the genus Usnea by UHPLC-ESI-OT-MS-MS","volume":"23","author":"Salgado","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e21742_bib39","first-page":"317","article-title":"Review of usnic acid and Usnea barbata toxicity","volume":"26","author":"Guo","year":"2008","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.heliyon.2023.e21742_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195995","article-title":"The natural compound hydrophobic usnic acid and hydrophilic potassium usnate derivative: applications and comparisons","volume":"26","author":"Araujo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e21742_bib41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0031-9422(02)00383-7","volume":"61","author":"Ing\u00f3lfsd\u00f3ttr","year":"2002","journal-title":"Usnic acid, Phytochemistry"},{"key":"10.1016\/j.heliyon.2023.e21742_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1063645","article-title":"Phytochemical composition, antimicrobial activities, and cholinesterase inhibitory properties of the lichen Usnea diffracta Vain","volume":"10","author":"Hao","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.heliyon.2023.e21742_bib43","first-page":"852","article-title":"New dibenzofuran and anthraquinone from Usnea longissima","volume":"34","author":"Feng","year":"2009","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"10.1016\/j.heliyon.2023.e21742_bib44","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1021\/acs.jnatprod.6b00109","article-title":"Usnic acid derivatives with cytotoxic and antifungal activities from the lichen Usnea longissima","volume":"79","author":"Yu","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.heliyon.2023.e21742_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2023.e21742_bib46","doi-asserted-by":"crossref","first-page":"D464","DOI":"10.1093\/nar\/gky1004","article-title":"RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy","volume":"47","author":"Burley","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2023.e21742_bib47","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.heliyon.2023.e21742_bib48","article-title":"SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: an in silico study","volume":"1","author":"Wong","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2023.e21742_bib49","unstructured":"PyMOL | www.pymol.org, (n.d.). https:\/\/www.pymol.org\/pymol.html? (accessed September 11, 2022)."},{"key":"10.1016\/j.heliyon.2023.e21742_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2023.e21742_bib52","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.3390\/ijms20184612","article-title":"Application of the SwissDrugDesign online resources in virtual screening","volume":"20","author":"Daina","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e21742_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/computation10010007","article-title":"Virtual combinatorial library screening of quinadoline B derivatives against SARS-CoV-2 RNA-dependent RNA polymerase","volume":"10","author":"Brogi","year":"2022","journal-title":"Computation"},{"key":"10.1016\/j.heliyon.2023.e21742_bib54","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1021\/acsomega.1c00137","article-title":"Potential cancer- and alzheimer's disease-targeting phosphodiesterase inhibitors from uvaria alba: insights from in vitro and consensus virtual screening","volume":"6","author":"Quimque","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.heliyon.2023.e21742_bib55","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e21742_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.644850","article-title":"Why haven't we found an effective treatment for COVID-19?","volume":"12","author":"Spicer","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.757826","article-title":"Repurposing of drugs for SARS-CoV-2 using inverse docking fingerprints","volume":"9","author":"Juki\u010d","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.heliyon.2023.e21742_bib58","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2023.e21742_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.622898","article-title":"Structural basis of potential inhibitors targeting SARS-CoV-2 main protease","volume":"9","author":"Mengist","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.heliyon.2023.e21742_bib60","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e21742_bib61","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib62","article-title":"Cytokine storm: the primary determinant for the pathophysiological evolution of COVID-19 deterioration","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e21742_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e21742_bib64","doi-asserted-by":"crossref","first-page":"E521","DOI":"10.1503\/cmaj.210066","article-title":"Tocilizumab for hospitalized patients with COVID-19","volume":"193","author":"Afra","year":"2021","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.heliyon.2023.e21742_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9459047","article-title":"Natural products for infectious diseases","volume":"2016","author":"Kim","year":"2016","journal-title":"Evid Based Complement Altern. Med."},{"key":"10.1016\/j.heliyon.2023.e21742_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/vew014","article-title":"Antiviral drug resistance as an adaptive process","volume":"2","author":"Irwin","year":"2016","journal-title":"Virus Evol"},{"key":"10.1016\/j.heliyon.2023.e21742_bib67","first-page":"2367","article-title":"Sars-Cov-2 and risk of antiviral drug resistance, Ir","volume":"191","author":"Vitiello","year":"2022","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.heliyon.2023.e21742_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009929","article-title":"In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2","volume":"17","author":"Szemiel","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2023.e21742_bib69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-802103-3.00006-7","article-title":"Clinical pharmacokinetics and drug interactions","author":"Saha","year":"2018","journal-title":"Pharm. Med. Transl. Clin. Res."},{"key":"10.1016\/j.heliyon.2023.e21742_bib70","first-page":"601","article-title":"Pharmacokinetic drug-drug interaction and their implication in clinical management","volume":"18","author":"Palleria","year":"2013","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.heliyon.2023.e21742_bib71","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cpt.1434","article-title":"Pharmacodynamic drug-drug interactions","volume":"105","author":"Niu","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2023.e21742_bib72","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.mpaic.2017.04.006","article-title":"Mechanisms of drug interactions: pharmacodynamics and pharmacokinetics","volume":"18","author":"Corrie","year":"2017","journal-title":"Anaesth. Intensive Care Med."},{"key":"10.1016\/j.heliyon.2023.e21742_bib73","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jbi.2017.04.021","article-title":"Computational prediction of drug-drug interactions based on drugs functional similarities","volume":"70","author":"Ferdousi","year":"2017","journal-title":"J. Biomed. Inf."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023089508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023089508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:39:57Z","timestamp":1791293997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023089508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2405844023089508"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21742","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e21742"}}